1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasopharyngeal Swabs Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasopharyngeal Swabs Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Technological Advancements
5.3. Epidemiology of Infectious Diseases, by Country/Region
5.4. COVID-19 Pandemic Impact on Industry
6. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Foam Tipped Swabs
6.3.2. Non-woven Swabs
6.3.3. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Influenza
7.3.2. COVID-19
7.3.3. Respiratory Syncytial Virus
7.3.4. Bordetella Pertussis Infection
7.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Nasopharyngeal Swabs Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Academia & Research Institutes
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Nasopharyngeal Swabs Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017-2031
10.2.1. Foam Tipped Swabs
10.2.2. Non-woven Swabs
10.2.3. Others
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Influenza
10.3.2. COVID-19
10.3.3. Respiratory Syncytial Virus
10.3.4. Bordetella Pertussis Infection
10.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Academia & Research Institutes
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Nasopharyngeal Swabs Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2031
11.2.1. Foam Tipped Swabs
11.2.2. Non-woven Swabs
11.2.3. Others
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Influenza
11.3.2. COVID-19
11.3.3. Respiratory Syncytial Virus
11.3.4. Bordetella Pertussis Infection
11.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Academia & Research Institutes
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Nasopharyngeal Swabs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Foam Tipped Swabs
12.2.2. Non-woven Swabs
12.2.3. Others
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Influenza
12.3.2. COVID-19
12.3.3. Respiratory Syncytial Virus
12.3.4. Bordetella Pertussis Infection
12.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Academia & Research Institutes
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Nasopharyngeal Swabs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Foam Tipped Swabs
13.2.2. Non-woven Swabs
13.2.3. Others
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Influenza
13.3.2. COVID-19
13.3.3. Respiratory Syncytial Virus
13.3.4. Bordetella Pertussis Infection
13.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Academia & Research Institutes
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Nasopharyngeal Swabs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Foam Tipped Swabs
14.2.2. Non-woven Swabs
14.2.3. Others
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Influenza
14.3.2. COVID-19
14.3.3. Respiratory Syncytial Virus
14.3.4. Bordetella Pertussis Infection
14.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Academia & Research Institutes
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Medical Wire & Equipment (MWE)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Titan Biotech Ltd.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. COPAN Diagnostics, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Miraclean Technology Co., Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Puritan Medical Products
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. YOCON Biology
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Trinity Biotech
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. VIRCELL S.L.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Quidel Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview
Table 1: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 2: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 3: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 4: Global Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 5: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 6: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 7: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 8: North America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 9: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 10: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 11: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 12: Europe Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 13: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 14: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 15: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 17: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 18: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 19: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 20: Latin America Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 21: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 22: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Application, 2017-2031
Table 23: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 24: Middle East and Africa Nasopharyngeal Swabs Market Size (US$ Mn) Forecast, by Region, 2017-2031
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
